Application of engineered antibodies (scFvs and nanobodies) targeting pathological protein aggregates in Alzheimer's disease
{{output}}
Introduction: The misfolding and aggregation of proteins are associated with various neurodegenerative diseases, such as Alzheimer's disease (AD). The small-molecule engineered antibodies, such as single-chain fragment variable (... ...
